首页> 外文期刊>Tissue Engineering Part A >Bombyx mori Silk Fibroin Membranes as Potential Substrata for Epithelial Constructs Used in the Management of Ocular Surface Disorders
【24h】

Bombyx mori Silk Fibroin Membranes as Potential Substrata for Epithelial Constructs Used in the Management of Ocular Surface Disorders

机译:家蚕丝素蛋白膜作为上皮构建物在眼表疾病管理中的潜在基质

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Membranes were prepared from fibroin, a protein isolated from the domesticated silkworm (Bombyx mori) silk, and evaluated as a potential substratum for corneal limbal epithelial cells. These membranes (i.e., B. mori silk fibroin [BMSF] membranes) were cast from dialyzed solutions of fibroin protein (4% w/v) dispensed into 35-mm-diameter culture dishes and dried at room temperature (23–24°C). The resulting material was transparent, easy to handle, and supported levels of human limbal epithelial (HLE) cell growth comparable to that observed on tissue culture plastic. Remarkably, these results were obtained utilizing a commercial serum-free medium (CnT-20) designed for the ex vivo expansion of corneal epithelial progenitor cells. The potential benefits of serum proteins on this culture system were examined through addition of fetal bovine serum (FBS) either to fibroin stocks prior to membrane casting or by supplementation of the CnT-20 medium. Membranes cast in the presence of FBS displayed increasing opacity and induced little change in HLE growth. Supplementation of CnT-20 medium with FBS deterred cell growth on all substrata, including tissue culture plastic control substrata. The remarkable properties of BMSF membranes demonstrated under serum-free conditions warrant investigation of this material as a substratum in the creation of tissue-engineered constructs for the restoration of diseased or damaged ocular surface.
机译:从纤维蛋白(从家蚕(Bombyx mori)蚕丝中分离出的蛋白质)制备膜,并评估其为角膜缘上皮细胞的潜在基质。这些膜(即桑蚕丝纤蛋白[BMSF]膜)是从分配到35毫米直径培养皿中的纤维蛋白蛋白(4%w / v)的透析溶液中浇铸而成的,并在室温(23–24°C)下干燥)。所得的材料是透明的,易于处理的,并且与组织培养塑料上观察到的水平相当,可支撑人角膜缘上皮(HLE)细胞的生长。值得注意的是,这些结果是利用设计用于离体扩张角膜上皮祖细胞的市售无血清培养基(CnT-20)获得的。通过在膜浇铸之前向纤维蛋白原液中添加胎牛血清(FBS)或通过补充CnT-20培养基,检查了血清蛋白对该培养系统的潜在益处。在FBS存在下浇铸的膜显示出增加的不透明性,并导致HLE生长几乎没有变化。用FBS补充CnT-20培养基可以阻止所有基质(包括组织培养塑料对照基质)上的细胞生长。在无血清条件下证明的BMSF膜的卓越性能,值得研究将该材料作为组织工程化构建体的基础,以修复患病或受损的眼表。

著录项

  • 来源
    《Tissue Engineering Part A》 |2008年第7期|1203-1211|共9页
  • 作者单位

    Queensland Eye Institute, Brisbane, Australia.|School of Physical and Chemical Sciences, Queensland University of Technology, Brisbane, Australia.|Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Australia.|Faculty of Health Sciences, School of Medicine, University of Queensland, Brisbane, Australia.;

    Queensland Eye Institute, Brisbane, Australia.;

    Queensland Eye Institute, Brisbane, Australia.|Faculty of Health Sciences, School of Medicine, University of Queensland, Brisbane, Australia.;

    Queensland Eye Institute, Brisbane, Australia.|School of Life Sciences, Queensland University of Technology, Brisbane, Australia.|Vision Improvement Domain, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.;

    Queensland Eye Institute, Brisbane, Australia.|Faculty of Health Sciences, School of Medicine, University of Queensland, Brisbane, Australia.|Department of Ophthalmology and Visual Science, University of California, Davis, California.;

    Queensland Eye Institute, Brisbane, Australia.|Faculty of Health Sciences, School of Medicine, University of Queensland, Brisbane, Australia.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号